Stereoselective increase in cholinergic transmission by R-(+)-hyoscyamine

Neuropharmacology

Volumn 36, Issue 3, 1997, Pages 281-294

  Ghelardini, C ^a   Gualtieri, F ^a   Romanelli, M Novella ^a   Angeli, P ^b   Pepeu, G ^a   Giovannini, M Grazia ^a   Casamenti, F ^a   Malmberg Aiello, P ^a   Giotti, A ^a   Bartolini, A ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF CAMERINO   (Italy)

Author keywords

acetylcholine; analgesia; atropine; autoreceptor; cholinergic; hyos cyamine; learning; memory; muscarinic; pain

Indexed keywords

3 AMINOPROPYL(DIETHOXYMETHYL)PHOSPHINIC ACID; 4 AMINO 5 CHLORO 2 METHOXYBENZOIC ACID 2 (DIETHYLAMINO)ETHYL ESTER; ACETYLCHOLINE; ATROPINE; BACLOFEN; CHOLINE; DICYCLOVERINE; HEMICHOLINIUM 3; HYOSCYAMINE; MORPHINE; MUSCARINIC M1 RECEPTOR; MUSCARINIC M2 RECEPTOR; MUSCARINIC M3 RECEPTOR; MUSCARINIC M4 RECEPTOR; MUSCARINIC M5 RECEPTOR; MUSCARINIC RECEPTOR; NALOXONE; NICOTINE; OXOTREMORINE; PHYSOSTIGMINE; PIRENZEPINE; PROPRANOLOL; QUINPIROLE; QUISQUALIC ACID; RADIOISOTOPE; RESERPINE; SCOPOLAMINE; YOHIMBINE;

ACETYLCHOLINE RELEASE; ANALGESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CHINESE HAMSTER; CHOLINERGIC TRANSMISSION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENANTIOMER; GUINEA PIG; HEART ATRIUM; HEMIDIAPHRAGM; ILEUM; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; LEARNING; MALE; MEMORY; MICRODIALYSIS; MOUSE; NONHUMAN; OOCYTE; PASSIVE AVOIDANCE; PHRENIC NERVE; PRIORITY JOURNAL; RABBIT; RAT; RECEPTOR AFFINITY; STEREOSPECIFICITY; VAS DEFERENS;

EID: 17644443193     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(97)83761-6     Document Type: Article

References (57)

1. Arunlakshna O., Schild H.O. Some quantitative uses of drug antagonist. Br. J. Pharmacol. 1:1959;48-58.
2. 2) receptors. Br. J. Pharmacol. 89:1986;439-444.
3. Barlow R.B., Frank F.M., Pearson D.M. Studies on the stereospecificity of closed related compounds which block postganglionic acetylcholine receptors in the guinea-pig ileum. J. Med. Chem. 16:1973;439-446.
4. Bartolini A., Galli A., Ghelardini C., Giotti A., Malcangio M., Malmberg-Aiello P., Zucchi P.L. Antinociception induced by systemic administration of local anaesthetics depends on a central cholinergic mechanism. Br. J. Pharmacol. 92:1987;711-721.
5. Bartolini A., Ghelardini C., Fantetti L., Malcangio M., Malmberg-Aiello P., Giotti A. Role of muscarinic receptor subtypes in central antinociception. Br. J. Pharmacol. 105:1992;77-82.
6. Bertels-Meeuws M.M., Polak L. Influence of antimuscarinic substances on in vitro synthesis of acetylcholine by rat cerebral cortex. Br. J. Pharmacol. Chemother. 33:1968;368-380.
7. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
8. Brown J.H. (1990) Atropine, scopolamine and related antimuscarinic drugs In: The Pharmacological Basis of Therapeutics (Goodman Gilman A., Rall T.W., Nies A.S. and Taylor P. Eds), pp. 33-48. Pergamon Press, Oxford.
9. Bülbring E. Observations on the isolated phrenic nerve diaphragm preparation on the rat. Br. J. Pharmacol. 1:1946;38-61.
10. Calhoun W., Smith H. Effects of scopolamine on acquisition of passive-avoidance. Psychopharmacologia. 13:1968;201-209.
11. Caufield M.P., Higgins G.A., Straughan D.W. Central administration of the muscarinic receptor subtype-selective antagonist pirenzepine selectively impairs passive avoidance learning in the mouse. J. Pharm. Pharmacol. 35:1983;131-132.
12. Chen C., Okayama H. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7:1987;2745-2752.
13. 4 receptor stimulation facilitates acetylcholine release in frontal cortex. Neuroreport. 5:1994;1230-1232.
14. Damsma G., Lammerts Van Bueren D., Westerink B.H.C., Horn A.S. Determination of acetylcholine in the femtomole range by means of HPLC, a post-column enzyme reactor, and electrochemical detection. Chromatographia. 24:1987;827-831.
15. De Belleroche J., Contino-Netto J., Bradforf H.J. Dopamine inhibition of the release of endogenous ACh from corpus striatum and cerebral cortex in tissue slices and synaptosomes: a presynaptic response? J. Neurochem. 39:1982;217-222.
16. Dörje F., Wess J., Lambrecht G., Tacke R., Mutschler E., Brann M.R. Antagonist binding profile of five cloned human muscarinic receptor subtypes. J. Pharmacol. Exp. Ther. 256:1991;727-732.
17. 2 receptors mediating opposite effects on neuromuscular transmission in rabbit vas deferens. Eur. J. Pharmacol. 151:1988;205-221.
18. Ferguson-Anderson W. (1952) Action of belladonna on gastric motility in man. Lancet (ii): 255-258.
19. Fonnum F. A rapid radiochemical method for the determination of choline acetyltransferase. J. Neurochem. 24:1975;407-409.
20. Galeotti N., Ghelardini C., Bartolini A. Involvement of the serotoninergic system in the analgesic effect of tryciclic antidepressants. Behav. Pharmacol. 6(Suppl. 1):1995;20.
21. Ghelardini C., Dei S., Giotti A., Gualtieri F., Malmberg-Aiello P., Teodori E., Bartolini A. Presynaptic cholinergic mechanism of R-(+)-hyoscyamine activity: in vitro studies. Pharmacol. Res. 1(Suppl.):1992;322.
22. Ghelardini C., Fanfani L., Galeotti N., Giotti A., Gualtieri F., Scapecchi S., Teodori E., Bartolini A. Effect of R-(+)-hyoscyamine on learning and dicyclomine induced amnesia. Neurosci. Lett. 43(Suppl.):1992;S52.
23. 4 agonists: BIMU-1 and BIMU-8 induce analgesia by facilitating central cholinergic transmission. Soc. Neurosci. 19: abstr. 565.2, 1378.
24. Ghelardini C., Giotti A., Gualtieri F., Matucci R., Romanelli M.N., Scapecchi S., Teodori E. and Bartolini A. (1992c) Presynaptic auto- and hetero-receptors in the cholinergic regulation of pain. In: Trends in Receptor Research (Angeli P., Gulini U. and Quaglia W., Eds), pp. 95-114. Elsevier Science, Amsterdam.
25. Ghelardini C., Gualtieri F., Baldini M., Dei S., Romanelli M.N., Giotti A., Bartolini A. R-(+)-Hyoscyamine: the first selective antagonist for guinea-pig uterus muscarinic receptor subtypes. Life Sci. 52(5/6):1993;569.
26. Gherlardini C., Malmberg-Aiello P., Giotti A., Malcangio M., Bartolini A. Investigation into atropine-induced antinociception. Br. J. Pharmacol. 101:1990;49-54.
27. 1 muscarinic receptor antagonists trihexyphenidyl and dicyclomine. Br. J. Pharmacol. 89:1986;83-90.
28. Giovannini M.G., Casamenti F., Nistri A., Paoli F., Pepeu G. Effect of thyrotropin releasing hormone (TRH) on acetylcholine release from different brain areas investigated by microdialysis. Br. J. Pharmacol. 102:1991;363-368.
29. Giovannini M.G., Mutolo D., Bianchi L., Michelassi A., Pepeu G. NMDA receptor antagonists decrease GABA outflow from the septum and increase acethylcholine outflow from the hippocampus: a microdialysis study. J. Neurosci. 14(3):1994;1358-1365.
30. Gualtieri F., Romanelli M.N., Scapecchi S., Teodori E., Bartolini A., Fantetti L., Ghelardini C., Giotti A. Muscarinic presynaptic autoreceptors and muscarinic postsynaptic receptors have opposital stereochemical requirements. Med. Chem. Res. 1:1991;50-58.
31. Haley T.J., McCormic W.G. Pharmacological effects produced by intracerebral injections of drugs in the conscious mouse. Br. J. Pharmacol. Chemother. 12:1957;12-15.
32. Irwing S. Comprensive observational assessment: Ia. A systematic, quantitative procedure for assessing the behavioral and physiologic state of mouse. Psychopharmacology. 13:1966;222-257.
33. 4 subtypes of muscarinic receptors in transfected CHO cells and muscarinic receptors in the heart cells revealed by negative antagonists. FEBS Lett. 277:1995;275-279.
34. Jarvik M.E., Kopp R. An improved one-trial passive avoidance learning situation. Psychol. Rep. 21:1967;221-224.
35. Kenanin T. Agonist-receptor efficacy L mechanisms of efficacy and receptor promiscuity. T.I.P.S. 16:1995;188-192.
36. Koster R., Andersen M., De Beer E.J. Acetic acid for analgesic screening. Fed. Proc. 18:1959;412.
37. Kuribara H., Higuchi Y., Takadoro S. Effects of central depressants on rota-rod and traction performances in mice. Japan. J. Pharmacol. 27:1977;117-126.
38. Leff P. The two-state model of receptor activation. T.I.P.S. 16:1995;89-97.
39. Lefkowtz R.J., Cotecchia S., Costa T. Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins. T.I.P.S. 14:1993;303-307.
40. Leighton G.E., Rodrigues R.E., Hill R.G., Hughes J. k-Opioid agonist produce antinociception after i.v. and i.c.v. but not intrathecal administration in the rat. Br. J. Pharmacol. 93:1988;553-560.
41. Lenke D. Narkosepotenzierende und Analgetische Wirkung von 1,4-dipyrrolidino-2-butin. Exp. Pathol. Pharmacol. 234:1958;35-45.
42. Malcangio M., Ghelardini C., Giotti A., Malmberg-Aiello P., Bartolini A. CGP-35348, a new GABA-B antagonist prevents antinociception and muscle-relaxant effect induced by baclofen. Br. J. Pharmacol. 103:1991;1303-1308.
43. Milligan G., Bond R.A., Lee M. Inverse agonism: pharmacological curiosity or potential therapeutic strategy? T.I.P.S. 16:1995;10-13.
44. Mitchell J.F. The spontaneous and evoked release of acetylcholine from the cerebral cortex. J. Physiol. Lond. 165:1963;98-116.
45. O'Callaghan J.P., Holtzman S.G. Prenatal administration of morphine to the rat: tolerance to the analgesic effect of morphine in the offspring. J. Pharmacol. Exp. Ther. 197:1976;533-544.
46. Paton W.D.M., Vizi E.S. The inhibitory action of noradrenaline on acetylcholine output by guinea-pig longitudinal muscle strip. Br. J. Pharmacol. 35:1969;10-28.
47. Paton W.D.M., Zar A. The origin of acetylcholine release from guinea-pig ileum. J. Physiol. Lond. 179:1968;85-86.
48. Paxinos G. and Watson G. (1982) The Rat Brain in Sterotaxic Coordinates. Academic Press, New York.
49. Prado W.A., Corrado A.P. Cholinergic agonist and antagonist interactions on motor nerve endings of rat - evidence for the involvement of presynaptic receptors in the regulation of acetylcholine release. Gen. Pharmacol. 18(1):1987;75-81.
50. Richardson R.T., Delong M.R. A reappraisal of the functions of the nucleus basalis of Meynert. Trends Neurosci. 11(6):1988;264-267.
51. 4 agonist endowed with potent antinociceptive activity. Arzneim. Forsch/Drug Res. II. 43(8):1993;913-918.
52. 1 receptors in dopaminergic control of striatal cholinergic transmission. Life Sci. 31:1982;2883-2890.
53. 2 and receptor differentiation: statistical analysis of competitive antagonism. Life Sci. 25:1979;637-654.
54. Van Rossum J.M. Cumulative dose-response curves. Technique for the making of dose-response curves in isolated organs and evaluation of drug parameters. Arch. Int. Pharmacodyn. Ther. 143:1963;229-330.
55. Wallace J.E., Krauter E.E., Campbell B.A. Motor and reflexive behavior in the aging rat. J. Gerontol. 35:1980;364-370.
56. Weiner N. (1980) Atropine, scopolamine and related antimuscarinic drugs In: The Pharmacological Basis of Therapeutics (Goodman Gilman A., Goodman L.S. and Gilman A. Eds), pp. 120-137. Pergamon Press, Oxford.
57. 3H]-acetylcholine from a modified rat phrenic nerve-hemidiaphragm preparation. Naunyn-Schmiedeberg's Arch. Pharmacol. 334:1986;357-364.